Loading data
MDLNNasdaq
| Unit: USD | FY2025 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 28.43 bn USD | — | 25.51 bn USD | 23.23 bn USD |
| Cost of revenue | 20.91 bn USD | — | 18.53 bn USD | 17.35 bn USD |
| Gross profit | 7.52 bn USD | — | 6.98 bn USD | 5.89 bn USD |
| Research and development expense | 80 m USD | — | 67 m USD | 60 m USD |
| Selling, general and administrative expense | 4.52 bn USD | — | 4.11 bn USD | 3.87 bn USD |
| Operating profit | 2.21 bn USD | — | 2.15 bn USD | 1.25 bn USD |
| Profit before tax | 1.25 bn USD | — | 1.25 bn USD | 264 m USD |
| Income tax expense | 91 m USD | — | 46 m USD | 30 m USD |
| Net income (reported basis) | 1,157 bn USD | 1.15 bn USD | 1.16 bn USD | 234 m USD |
| Basic earnings per share | -0.01 USD/share | — | — | — |
| Diluted earnings per share | -0.01 USD/share | — | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.